Chronic Non Specific Low Back Pain
Conditions
Keywords
chronic non specific low back pain, integrated nouromuscular inhibition technique, instrument assisted soft tissue mobilization technique
Brief summary
this study will be conducted to identify the difference between the effect of integrated neuromuscular inhibition technique and instrument assisted soft tissue mobilization on back pain, pain threshold, back rang of motion ,back proprioception and back disability in chronic non specific low back pain
Interventions
will receive integrated neuromuscular inhibition in addition to conventional treatment,INIT which included IC, SCS, and MET for the low back region for the quadratus lumborum( QL) and erector spinae (ES) muscles
IASTM performed on lumbar posterior muscle erector spinae (iliocostalis, longissimus), and quadratus lumborum(QL) The IASTM treatment was applied for approximately 20-seconds in a direction parallel to the muscle fibers being treated with the instrument at a 45° angle. Followed immediately by treating the muscles in a direction perpendicular to the muscle fibers with the instrument at a 45° angle for an additional 20-seconds, resulting in a total treatment time of approximately 40 seconds.
. The control group will applied general exercise. General exercise were applied with stretching exercises and stationary bicycling for 10-15 minutes14, 15) . Three sets of fifteen repetitions will performed, with rest times of 1 minute between sets during 4 weeks.
Sponsors
Study design
Masking description
Double ( participant ,outcomes assessor)
Intervention model description
1. integrated neuromuscular inhibition technique and conventional physical therapy 2. instrument assisted soft tissue mobilization technique and conventional physical therapy 3. conventional physical therapy only
Eligibility
Inclusion criteria
* 1\. The patient's age ranged from 18 to 30 years.(Geogre et al, 2021) 2. Patients with low back pain for more than 3 months (pain felt between T12 and the gluteal fold). 3\. Patient with chronic low back pain 4. Normal body mass index from 18 -25kg/m2.
Exclusion criteria
* The subjects will be excluded if they have any of the followings: 1. Lumbar discogenic lesions or any inflammatory arthritis, tumors, infection involving the lumbar spine. 2. Patients with decreased range of motion secondary to congenital anomalies, muscular contracture, or bony block. 3. Previous lumbar or hip surgery or trauma. 4. Any hip structural abnormality such as malformations, impingements and degeneration. 5. Patients With cognitive impairments that would limit their participation
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| change in lumber proprioception | Evaluation will be performed priod to the first treatment session :as a baseline measure,and at least treatment session (after 4 weeks)as a post-treatment measure | change in lumbar proprioception will be measured by dual inclinometer for 3 group pre-and post-treatment |
| chang in pain pressure threshold | Evaluation will be performed priod to the first treatment session :as a baseline measure,and at least treatment session (after 4 weeks)as a post-treatment measure | change in lower back pain threshold will be measured by pressure algometer for 3 group pre-and post-treatment |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| chang in lumbar rang of motion(ROM) | Evaluation will be performed priod to the first treatment session :as a baseline measure,and at least treatment session (after 4 weeks)as a post-treatment measure | lumbar ROM will be measured by dual inclinometer pre-treatment and post treatment |
| functional disability oFlumbar spine | Evaluation will be performed priod to the first treatment session :as a baseline measure,and at least treatment session (after 4 weeks)as a post-treatment measure | functional disability will be measured by The Arabic version of Oswestry Disability Index.(ODI) |
| pain level of lumbar spine | Evaluation will be performed priod to the first treatment session :as a baseline measure,and at least treatment session (after 4 weeks)as a post-treatment measure | pain level will be measured by visual analoge scale(VAS) |